New study by Professor Yoon-Kyoung Cho validates urine-based biomarkers for early detection of cancer.
A team of researchers, led by Professor Yoon-Kyoung Cho of Life Science at UNIST has recently developed a new technique that effectively identifies cancer-causing substances in the urine or blood.
In the study, Professor Yoon-Kyoung Cho of Life Science, a group leader at IBS Research Center for Soft and Living Matter (CSLM) presented an integrated centrifugal microfluidic
platform (Exodisc), a device that isolates extracellular vesicles (EVs) from urine.
The results of the study has been published in the February issue of ACS Nano journal. The research team expects that this may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics.
Despite the increasing clinical importance of EVs as potential biomarkers in the diagnosis and prognosis of various diseases, current methods of EV isolation and analysis suffer from complicated procedures with long processing times. For instance, even ultracentrifugation (UC), the most commonly used method for EV isolation, requires time-consuming steps involving centrifugation and acquisition of large sample volumes, and the results suffer from low yield and purity.
To overcome these limitations, Professor Cho presented a new lab-on-a-disc platform for rapid, size-selective, and efficient isolation and analysis of nanoscale EVs from raw biological samples, such as cell-culture supernatant (CCS) or cancer-patient urine.
“The Exodisc is compoased of two independent filteration units (20nm and 600nm in size) within a disk-shaped chip to enable the processing of two different samples simulateously,” says Hyun-Kyung Woo (Combined M.S./Ph.D. student of Natural Science), the first author of the study. “Upon spinning the disc, the urine sample is transferred through two integrated nanofilters, allowing for the enrichment of unirary EVs within the size range of 20 to 600 nm.”
The hole sizes in nanoporous filters mounted on the Exodisc were set arbitrarily to seperate the nanoscale vesicles effectively from germs or unnecessary proteins. The direct detection of urinary EVs from patients with bladder cancer was validated successfully, using on-disc enzyme-linked immunosorbent assay (ELISA).
“Using Exodisc, it is possible to isolate EVs from raw samples within 30 minutes,” says Professor Cho. “The process of passing the filter through centrifugal force is automatically carried out, effectively recovering the enriched EVs.”
In the study, the research team examined clinical samples by analyzing urinary EVs from bladder cancer patients, using a tabletop-sized centrifugal microfluidic system. As a result, fully automated enrichment of unirary EVs in the size range of 20?600 nm was achieved within 30 min Quantitative tests.
“On-disc ELISA using urinary EVs isolated from bladder cancer patients showed high levels of CD9 and CD81 expression, suggesting that this method may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics,” says Vijaya Sunkara of Life Sciences, the co-first author.
“We are currently conducting further studies to determine various diseases, including cancer by analyzing the collected nanoparticles,” says Professor Cho. “We hope this device can contribute significantly to the advancement of studies related to tumor biology and acceleration of the practical use of EV-based liquid biopsies for personalized medicine in clinical settings,” says Professor Cho.
Receive an email update when we add a new CANCER DIAGNOSTICS article.
The Latest on: Cancer diagnostics
via Google News
The Latest on: Cancer diagnostics
- ‘It hasn’t stopped me from running’: Flint man runs in Crim after cancer diagnosison August 28, 2021 at 11:02 am
Fremont Halboth began racing in the Crim 30 years ago to be an example for his patients and family. Today, he’s racing to keep his health in top shape after recently getting a cancer diagnosis. “I was ...
- Minecraft YouTuber Technoblade reveals cancer diagnosis after mistaking arm pain for stress injury from playing gameson August 28, 2021 at 4:40 am
POPULAR Minecraft YouTuber Technoblade has revealed he has been diagnosed with cancer after taking a break from creating videos. The streamer started experiencing pain in his arm in July, and took ...
- Is Technoblade OK? YouTuber jokes about his cancer diagnosis, fans say 'stay strong'on August 27, 2021 at 7:35 pm
The Minecraft player, who was on a two-month hiatus revealed his cancer diagnosis on YouTube as he called healthcare provider 'the real victim' ...
- How 1 mom used her cancer diagnosis to inspire change in the beauty industryon August 27, 2021 at 12:35 pm
Kelsey Bucci created Paris Laundry, an e-commerce clean beauty destination, after being diagnosed with breast cancer at 30 years old.
- Sofia Vergara Says a Routine Checkup Led to Her Thyroid Cancer Diagnosis at 28on August 26, 2021 at 9:13 am
Sofia Vergara opened up about being diagnosed with thyroid cancer at 28. The actress, 48, emphasized the importance of routine checkups. “When you’re young and you hear that w ...
- Mark Hoppus shares text conversation that led to a checkup before cancer diagnosison August 26, 2021 at 8:35 am
Mark Hoppus stressed the importance of paying attention to changes in one's body through the viral "How It Started vs. How It's Going" challenge ...
- CMP hires new CEO as longtime leader steps back due to cancer diagnosison August 25, 2021 at 3:21 pm
Joseph Purington, a Maine native, comes to the utility from Eversource Energy, where he was president of New Hampshire operations.
- Mark Hoppus Shares His Cancer Diagnosis Story Through ‘How It Started vs. How It’s Going’ Poston August 25, 2021 at 12:42 pm
Mark Hoppus is taking his blink-182 fans through the full-circle journey of his cancer diagnosis by using the “How It Started vs. How It’s Going” social media trend.
- Cervical Cancer Diagnostics Global Market Report 2021 - ResearchAndMarkets.comon August 25, 2021 at 7:48 am
The "Cervical Cancer Diagnostics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global cervical cancer diagnostics ...
via Bing News